NY Times / Suboxone redux

  I thought I was done, but here are a couple more smart takes. Both support maintenance but appreciate the article raising awareness of important problems.   From The Institute Blog:   And as the articles (and the comment section) demonstrate, the use of buprenorphine to treat addiction and prevent substance use-related harms is messy.  Interlacing text and video, … Continue reading NY Times / Suboxone redux

Addiction Treatment With a Dark Side

The NY Times has a new piece on Suboxone. First, on its blockbuster status: Suboxone is the blockbuster drug most people have never heard of. Surpassing well-known medications like Viagra and Adderall, it generated $1.55 billion in United States sales last year, its success fueled by an exploding opioid abuse epidemic and the embrace of federal officials … Continue reading Addiction Treatment With a Dark Side

NIMH acknowledges that antipsychotics worsen prospects for long term recovery

Thomas Insel, the Director of the National Institute on Mental Health comments on a recent study of the long term effects of antipsychotic maintenance for schizophrenics. The study looked at patients who discontinued antipsychotics compared to those who were maintained on antipsychotics. ...by seven years, the discontinuation group had achieved twice the functional recovery rate: … Continue reading NIMH acknowledges that antipsychotics worsen prospects for long term recovery

NAATP launches counteroffensive to medication push

This is very welcome news: Frustrated that medication-assisted treatment is coming across as the addiction field’s standard of care simply because drug company studies are dominating the research landscape, a group of some of the most prominent leaders in treatment administration is vowing to fight back. These leaders have enlisted the help of another heavy … Continue reading NAATP launches counteroffensive to medication push

Hazelden to start opioid maintenance

This has gotten a lot of attention [emphasis mine]: ...for the first time, Hazelden will begin providing medication-assisted treatment for people hooked on heroin or opioid painkillers, starting at its Center City, Minnesota facility and expanding across its treatment network in five states in 2013.  This so-called maintenance therapy differs from simply detoxifying addicts until … Continue reading Hazelden to start opioid maintenance